checkAd

    DNAG - $$ Receives Notice of Allowance for Patent $$ - 500 Beiträge pro Seite

    eröffnet am 20.04.06 14:49:54 von
    neuester Beitrag 20.04.06 21:46:30 von
    Beiträge: 7
    ID: 1.054.966
    Aufrufe heute: 0
    Gesamt: 796
    Aktive User: 0

    ISIN: US23324Q2021 · WKN: A0ETWM · Symbol: DNAG
    0,0000
     
    USD
    0,00 %
    0,0000 USD
    Letzter Kurs 22.05.24 Nasdaq OTC

    Werte aus der Branche Biotechnologie

    WertpapierKursPerf. %
    0,8000+2.566,67
    3,3000+44,74
    1,2200+31,76
    1,2450+29,69
    7,7600+29,33
    WertpapierKursPerf. %
    2,7900-24,80
    1,0100-26,81
    9,5300-34,00
    1,2400-34,39
    1,0950-34,43

     Durchsuchen

    Begriffe und/oder Benutzer

     

    Top-Postings

     Ja Nein
      Avatar
      schrieb am 20.04.06 14:49:54
      Beitrag Nr. 1 ()
      heute wird die Post abgehen....
      jetzt noch schnell die 45min vorsprung nutzen und hier unter 0,02€ rein...:eek:

      liebe Grüße und hier die news:


      DNAPrint Genomics Receives Notice of Allowance for Patent for Identifying Links Between Gene Sequences and Medical Traits
      Thursday April 20, 7:00 am ET


      Sophisticated Technology Utilized by Company\'s DNAPrint Pharmaceuticals Subsidiary


      SARASOTA, FL--(MARKET WIRE)--Apr 20, 2006 -- DNAPrint Genomics, Inc. (OTC BBNAG.OB - News) today announced that the Company has received a Notice of Allowance from the U.S. Patent and Tradmark Office for a patent application, Methods for the Identification of Genetic Features for Complex Genetics Classifiers. The patent protects the Company\'s methods for identifying links between gene sequences and phenotypes (physical or medical traits).
      ADVERTISEMENT


      "Gene sequences are highly polymorphic in the population, which means that they come in various forms or \'flavors,\'" stated DNAPrint Genomics Founder and Chief Scientific Officer Tony N. Frudakis. "Polymorphism is usually measured at the level of the single nucleotide polymorphism (SNP) but our technology measures at the level of the haplotype (strings of SNPs), which provides researchers considerably more information. The methods covered in the patent allow for an efficient and powerful means for identifying haplotype."

      The recent patent provides legal protection for DNAPrint\'s status as one of a very few companies currently capable of performing objective, assumption-free haplotype analyses. DNAPrint is also the only company currently using Ancestry Informative Markers (AIMs) and has patents pending in this area as well. Because of limitations with traditional genome screening methods and the complex genetic characteristics of modern populations, AIMS are integral to the development of DNA tests for the inference of genetic ancestry based on phenotypes, including identifying certain physical characteristics, or an individual\'s predisposition to respond to certain drugs.

      "The Company is committed to developing a new class of drugs, called \'theranostics,\' which are test+drug combinations designed to help ensure that patients receive the appropriate medicine and proper dosage based on their genetic constitution. The application of theranostics is also designed to increase efficacy and reduce side-effects," said DNAPrint Chairman and Chief Medical Officer Hector J. Gomez, M.D., Ph.D. "Our sophisticated genetics technology is playing a key role in the research and development of potential new drugs."

      "This patent cuts across a wide audience of developers from drug companies to people working on technology in the forensics and consumer areas," stated DNAPrint President and Chief Executive Officer Richard Gabriel. "We plan to vigorously utilize and practice our patents and we will be reviewing the fields of genetic testing, drug development, forensic sciences and consumer products with our patent counsel to determine potential areas of development. We want to ensure that we extract the greatest economic value out of this patent for our shareholders and investors."

      DNAPrint Genomics currently holds two patents and has several others pending or in the hands of patent counsel.
      Avatar
      schrieb am 20.04.06 14:53:04
      Beitrag Nr. 2 ()
      und schon kommen die ersten direkten Empfehlungen:

      Market Pulse Announces Its AM Stock Picks for Thursday, April 20, 2006: FNSR, DNAG, EBAY, SATC


      ATLANTA, April 20, 2006 (PRIMEZONE) -- Market Pulse is pleased to announce the following stock recommendations. Bernard Schmitt of Market Pulse states, "These notable stocks should be watched because they look great from a fundamental and technical perspective." Bernard possesses many years of experience in the financial industry recommending and evaluating stocks. He rates them as follows:

      Finisar Corp. (Nasdaq: FNSR): Market Outperform

      :eek: DNAPrint Genomics Inc. (OTCBB: DNAG): Attractive :eek:

      eBay Inc. (Nasdaq: EBAY): Bearish

      SatCon Technology Corp. (Nasdaq: SATC): Attractive

      Recommendation Meanings

      These recommendations are investment opinions of Market-Pulse.com and reflect the stock's potential to move over the next one to four weeks of trading. This analysis is done from a technical and fundamental perspective.

      After The Bell Market Commentary

      According to Bernard Schmitt, "On Wednesday, higher gasoline prices lifted the Consumer Price Index 0.4% in March, well above the 0.1% increase in February. Excluding food and energy, core inflation rose 0.3%, the largest gain in a year. Light sweet crude for May delivery climbed as high as $72.40 a barrel, before settling at $72.17. Gold prices rose toward $650 an ounce, a 25-year high. Upbeat corporate earnings lifted the markets to a modestly higher close. The Dow Jones industrial average gained 10.00, or 0.09 percent, to 11,278.77. The Nasdaq composite index rose 14.74, or 0.63 percent, to 2,370.88, a five-year high. The Standard & Poor's 500 index adding 2.28, or 0.17 percent, to 1,309.93. The Russell 2000 index rose 8.61, or 1.12 percent, to 778.42."

      About Market-Pulse.com

      Grüße
      Svenja
      Avatar
      schrieb am 20.04.06 15:58:41
      Beitrag Nr. 3 ()
      danke für den tipp svenja :D !
      Avatar
      schrieb am 20.04.06 16:22:17
      Beitrag Nr. 4 ()
      RT 0,019€

      USA:
      Time Ex Price Change Volume
      10:00:56 Q 0.023 +0.0034 100,000

      10:00:56 Q 0.023 +0.0034 100,000

      09:59:32 Q 0.024 +0.0044 69,500

      09:58:29 Q 0.024 +0.0044 75,000

      09:58:19 Q 0.024 +0.0044 75,000

      09:58:09 Q 0.024 +0.0044 5,000

      09:57:29 Q 0.024 +0.0044 5,000

      09:56:39 Q 0.023 +0.0034 20,000

      09:55:27 Q 0.023 +0.0034 200,000

      09:54:37 Q 0.023 +0.0034 48,000


      ich denke so kann es weiter gehen..
      grüße
      svenja
      Avatar
      schrieb am 20.04.06 16:43:36
      Beitrag Nr. 5 ()
      We want to ensure that we extract the greatest economic value out of this patent for our shareholders and investors."

      :eek::eek::eek::eek:
      Gefällt mir gut der letzte Satz.:cool:

      Trading Spotlight

      Anzeige
      East Africa Metals
      0,1480EUR +0,68 %
      Hat East Africa bisher nur an der Oberfläche gekratzt?! mehr zur Aktie »
      Avatar
      schrieb am 20.04.06 18:06:44
      Beitrag Nr. 6 ()
      Bin mit von der Partie:)
      Avatar
      schrieb am 20.04.06 21:46:30
      Beitrag Nr. 7 ()
      Je später der Abend umso tiefer der Kurs. War wohl wie schon so oft nur heiße Luft.


      Beitrag zu dieser Diskussion schreiben


      Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
      Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie
      hier
      eine neue Diskussion.

      Investoren beobachten auch:

      WertpapierPerf. %
      +0,20
      0,00
      -0,94
      +2,52
      +1,63
      -0,37
      -0,69
      +2,65
      -0,63
      -1,10

      Meistdiskutiert

      WertpapierBeiträge
      59
      40
      20
      19
      19
      17
      17
      16
      15
      14
      DNAG - $$ Receives Notice of Allowance for Patent $$